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Summary
The T cell receptor a/(3 (TCR-a/O) is encoded by variable (V), diversity (D), joining (J), and
constant (C) segments assembled by recombination during thymocyte maturation to produce
a heterodimer that imparts antigenic specificity to the T cell. Unlike immunoglobulins (Igs),
which bind free antigen, the ligands of TCRa//3 are cell surface complexes of intracellularly
degraded antigens (i.e., peptides) bound to and presented by polymorphic products of the major
histocompatibility complex (MHC). Therefore, antigen recognition by T cells is defined as MHC
restricted. A model has been formulatedbased upon the similarity between TCR-a/(3 V region
and Ig Fab amino acid sequences, and the crystal structure of the MHC class I and Ig molecules.
This model predicts that the complementarity determining regions (CDR) 1 and 2, composed
ofTCR Va and V/3 segments, primarily contact residues of the MHC a helices, whereas V/Ja
and V/D/J(3 junctional regions (the CDR3 equivalent) contact the peptide in the MHC binding
groove. Because polymorphism in MHC proteins is limited relative to the enormous diversity
ofantigenic peptides, the TCR may have evolved to position the highly diversejunctional residues
(CDR3), where they have maximal contact with antigen bound in the MHC peptide groove.
Here, we demonstrate a definitive association between CDR3 sequences in both TCR a and
/3 chains, and differences in recognition of antigen fine specificity using a panel of I-Ed-restricted,
myoglobin-reactive T cell clones. Acquisition of these data relied in part upon a modification
of the polymerase chain reaction that uses a degenerate, consensus primer to amplify TCR a
chains without foreknowledge of the Vu segments they utilize.
T
he heterodimeric TCR-a/(3 is encoded by V, D, J, and
C segments assembled by recombination during thymo-
cyte maturation to produce a heterodimer that imparts spec-
ificity in antigen recognition to the T cell (1). Unlike Igs,
which bind free antigen, the ligands of TCR-a/O are cell
surface complexes of intracellularly degraded antigens (i.e.,
peptides) bound to and presented by polymorphic products
of the MHC (2, 3) . Antigen recognition by T cells is there-
fore defined as MHC restricted. Based upon the similarity
between TCRa/(3 V region and Ig Fab amino acid sequences,
and the crystal structure of the MHC class I and Ig mole-
cules, a model of the TCR has been proposed (4, 5) . This
model predicts that the Ig complementarity determining re-
gion (CDR) equivalent of the TCR 1 and 2, composed of
the germ line-encoded TCR Va and V(3 segments, primarily
contact residues of the MHC a helices, whereas the highly
divergent V/Ja and V/D/Jojunctional regions (the Ig CDR3
equivalent) contact the peptide in the MHC binding groove.
Junctional sequence diversity is contributed by multiple factors:
combinatorial association of V, D, and J segments, transla-
tion of D(3 segments in all three reading frames, and enzyme-
catalyzed, template-independent addition and deletion ofnu-
cleotides between V, D, and J segments (4). Because poly-
morphism in MHC proteins is limited relative to the enormous
diversity of antigenic peptides, the TCR may have evolved
to position the highly diverse junctional residues (CDR3),
where they have maximal contact with antigen bound in the
MHC peptide pocket.
Using synthetic peptides, it has been possible to map the
minimal length and sequence of T cell epitopes in particular
MHC/antigen complexes (6-9). However, the conformational
flexibility ofpeptides and their effects upon the MHC binding
groove are as yet unknown. Furthermore, the structures of
the al and /31 peptide-binding domains of MHC class II
molecules can only be modeled from the crystallographic anal-
ysis of HLA-A2 (10), and will undoubtedly differ from their
class I counterparts. The recent structuralsolution of a second
class I molecule (Aw68) revealed small but potentially im-
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the two closely related molecules (11), suggesting that gen-
eralizations about thedetails of MHC/peptidecomplexesrec-
ognized by the TCR await additional high resolution anal-
yses. Despitethese limitations, investigation of therelationship
between TCR structure and ligaed recognition can be in-
formativein model systemsofcloned Tcellsspecific fordefined
peptides in thecontext of a single MHC-restricting element
(12-15). By comparison of TCR sequences expressed by T
cells with discrete differences in epitope fine specificity rec-
ognition, regions of the receptor chains that are important
for MHC vs. peptide recognition can be identified.
Here, we demonstrate an association betweenjunctional
sequences in both TCR a and /3 chains, and differences in
antigen fine specificity recognition using a panel of I-Ed-
restricted, myoglobin-reactive T cell clones. These data sub-
stantiate the proposed TCR modeldescribed above, especially
theimportanceofboth TCR a and #CDR3 regionsin pep-
tide contact. Acquisition of these data relied in part upon
a modification of the polymerase chain reaction (PCR)t that
uses adegenerate, consensusprimer to amplifyTCR achains




T cell clones were derived according to estab-
lished procedures (6, 16). Briefly, DBA/2 mice were immunized
at the base of the tail with 100-200 Pg sperm whale myoglobin
(SpWMb)/50% CFA, and the draining lymph nodes (LN) were
removed8dlater. TheLN cellswere cultured with irradiated, syn-
geneic spleen cells (APC) and SpWMb for 12 d. Cells were re-
stimulated three times with APC and the 56-131 cyanogen bro-
mide fragment ofSpWMbat 12-13-dintervals, and thebulk cultures
were cloned and subcloned by limiting dilution. Clone designa-
tions refer to mouse and clone (e.g., 8.2 is clone 2 derived from
mouse 8). Recognition of antigenic fine specificity by the clones
was assayed by restimulation of 10' rested T cells with 106 irradi-
ated APC and several concentrations of nested synthetic peptides.
Cell proliferation was measured by [3H]thymidine incorporation
and is expressed as the mean of triplicate cultures in cpm x 103.
RNA Isolation.
￿
Total RNA wasprepared from Ficoll-separated
T cells 3 d after restimulation with SpWMb by homogenization
of 5-10 x 106 cells in guanidine thiocyanate and centrifugation
throughcesium chloride (17). To elicit maximum TCRexpression
before RNA extraction and eliminate possible contamination by
feeder cell RNA, resting T cells (>10 d after last antigen stimula-
tion) were Ficoll purified, resuspended at 0.5-1.0 x 106/mlin media
containing 10 ng/ml PMA, 250ng/mlionomician, and10-25 U/ml
human rIL2 (Cetus Corp., Emeryville, CA). After 24 h, cultures
were diluted 1:2 to 1:4 into media containing rIL2 alone. A time
course experiment assaying TCR.mRNA levels by Northern blot
hybridization to Ca and Cf3 probes showed that 3-5 d of this
regimen produced optimal RNA levels for further analyses.
1LR-/3 PCR andSequence Analysis.
￿
A first strand cDNA syn-
thesis was performed on 10 mg of total RNA using oligo (dT)
priming of avian myeloblastosis virusreversetranscriptase (18), and
Abbreviations used in this paper . HMb, horse myoglobin; LN, lymph
nodes; PCR, polymerase chain reaction; SpWMb, sperm whale
myoglobin.
50% of thereaction was used as a template forPCRamplification.
The5' TCR-/3 8.2 probewas5'-ATGTCTAACACTGCCTT3'. The
3' C/3 probe was 5'-TCA GGA ATT TTT TTT CTT GAC-3'.
Theprimer annealingPCRsegmentwas 1 minat 55°C. Thepoly-
merase extension segment was 1 min at 72°C. A final 10-min ex-
tension was performed at 72°C to ensure fullyduplexed DNA for
optimal ligation efficiency. The entire coding region of theV08.2-
containing transcripts was amplified using twoprimers, L08.2 and
C02 (19, 20) by 25 cycles in athermal cycler (Perkin-Elmer Corp.,
Norwalk, CT) (21-23). Full-length products were purified as pre-
viously described (15) and cloned into M13 vectors. Plaques
hybridizing with a V,68.2 probe labelled with a32p-dCTP (24)
were identified, and a minimum of six subclones for each TCR
(3 chain were sequenced (25). Reactions were resolved on 40-cm
wedgegels and autoradiographed overnightat room temperature.
To eliminate possible sequence errors introduced either in the re-
verse transcription or Taqpolymerization reactions, moleculeswere
subcloned from independent PCR reactions and their sequences
compared. Sequences were analyzed on a VACS computer using
GenBank and EMBL data files.
TCR-a Consensus PCR.
￿
To determine the Va segments ex-
pressed by the DBA/2 clones, Northern transfers of RNA from
each clone were prepared by standard methods (26), and hybrid-
ized underconditions of high stringency to a collection of Vca re-
gion probes representing 11 of 13 known Va families (27-32). In-
clusion ofa sequence in a Vregion family was defined by adegree
ofnucleotide homology X85% (33). Results from thesestudies(data
not shown) defined clone 8.2 as expressing Va4. Oligonucleotide
primers forVa4andCa were designed basedupon published sequences
(27, 32), andused in PCR amplification of the TCR-a mRNA from
clone 8.2 as described for the TCR(3 chains. The sequence of the 5'
Va4 oligowas5'-CGC GAATTC ACCATGAACCTT TGTCCT
GAACTG-3'. The3' Ca primer hadthesequence 5'-TCA ACTGGA
CCACAGCCTCAG-3'. Despite crosshybridization to aVal probe
(TTll; reference27), PCRprimers designed from theleader sequence
ofthis clonefailed to amplify theTCR-a from clones 11.3, 12.2, 14.12,
and 14.16. Consequently, the consensus primer was used to obtain
the Va sequence data. In addition to the M13 primer, sequencing
primers for the achains were Ca5R 5'-CAG AACCCA GAA CCT
GCT GTG-3' and Ca4 5'-GCA CAT TGA TTT GGG AGT CA-3'.
PCR amplification ofTCRachains from clones expressing undefined
Va was accomplished with a 216-fold degenerate "consensus" oligo
forthe5' primer anda3' Ca primer. TheconsensusVa 5' PCRprimer,
purchasedfrom Operon Technologies (San Pablo, CA)hadthesequence
5'-TAAGCG GCC GCT GGT ACZ LMC AGC ATC CXG GMG
AAG GCC-3', where Z = 40% A, 40% G, 15% C, 5% T L = A,
G, T M = 45% A, 50% G, 5% C; X = C, T. It was used at a
1-pM final concentration in a 100-pl PCR reaction with 1 /AMCa3'
primer. The temperature ofannealingsegments wastwocycles at 37°C,
onecycle at 42°C, and 27 cycles at 55°C. Selection of these cyclepro-
grams was made empirically. Details of consensus primer specificity
and sensitivity will be describedelsewhere (Danska, J. S., and C. G.
Fathman, manuscript in preparation). The amplified product was
purified and cloned as described for the /3 chains. One modification
wasdigestionofthegelpurified products with NotI to exploitacloning
site in the Va consensus primer. The material was then ligated into
an M13derivative (mp21) digested with Hinc II and Not I. Multiple
subclones of the TCR a chains were sequenced as described for the
,Q chains.
Results
Fine Specificity Analysis of SpWMb-specfic T Cell Clones.
Mice of the H-2d haplotype generate class II-restricted Th
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cells that recognize multiple epitopes of SpWMb in associa-
tion with both I-Ad and I-Ed molecules (7-9). We have iso-
lated a series of Th cell clones (6, 34) that recognize at least
three distinct epitopes within SpWMb 110-121 and have de-
termined the sequence of their TCR. Differences in recogni-
tion of antigen fine specificity among the T cell clones was
examined using a nested set of synthetic SpWMb peptides
serially shortened on either the NHZ terminus or COOH
terminus, as well as horse myoglobin (HMb), which has an
arginine for lysine substitution at position 118. The clones
were divisible into three fine specificity groups (Fig. 1) . The
minimal epitope of four of the six clones (8.2, 9.4, 11.3, and
12.2), represented in Fig. 1 by 9.4, consisted of amino acids
112-118, and all four "prototype clones" were equally reac-
tive to SpW or HMb. A second fine specificity was observed
in clone 14.12; this clone was 112-118 specific but showed
diminished reactivityto HMb (Fig. 1 B) . A thirdclone, 14.16,
recognized a minimal epitope that consisted of amino acids
111-117 and recognizedboth species ofMb equally well (Fig.
1 C). Thus, among the six 110-121-reactive clones studied,
there were three distinct fine specificity patterns.
To determine MHC restriction, these clones were cocul-
tured with SpWMb and irradiated APC derived from mice
of different haplotypes. All six clones responded to SpWMb
and APC that expressed both I-Ad and I-Ed (DBA/2 or
MOM), but all failed to recognize SpWMb on APC bearing
only I-Ad (D2.GD), defining them as I-Ed restricted. The
clones were also assayed for reactivity to APC from mice of
10 additional MHC haplotypes either without exogenous an-
tigen (termed alloreactivity), or in the presence of SpWMb.
None of the clones responded to SpWMb presented on APC
from a non-H-2d animal; clone 14.12 alone had apparent al-






















Antigen fine specificity of
I-E'-restricted DBA/2 clones. Cell
proliferation assays were performed on
T cell clones stimulated with irradiated,
syngeneic APC, and truncated peptides
spanning amino acids 102-124 of
SpWMb. (A) Results for NHZ-terminal
truncations; (B) for COOH-terminal
truncations; and (C) for reactivity to
HMb that bears a substitution (boxed)
within the epitope recognized by these
clones. Column 9.4 represents the
specificity pattern of clone 9.4, character-
istic of the four prototype clones, in-
cluding 8.2, 11.3, and 12.2.
"prototypical" SpWMb 112-118-reactive clones (8.2, 9.4, 11.3,
12.2).
TCR (3 Chain Analysis.
￿
We undertook a molecular anal-
ysis of the TCRs used by these six SpWMb-reactive clones
to ask first whether the indistinguishable antigen specificity
of the four prototype clones reflected TCR primary sequence
similarity, and second, whether the observed differences in
epitope specificity and/or allorecognition were associatedwith
variation in particular portions of their TCR sequences. Prior
experiments using a TCR V08-specific mAb had revealed
that all six clones expressed either V(3 8.1 or V08.2 (34).
Southern and Northern blot analyses with both V08.1 and
V08.2 molecular probes (19, 20) confirmed that all six clones
had rearranged and transcribed Va8.2 (data not shown). Oli-
gonucleotide primers specific for the V08.2 leader and the
C02 sequences were used to PCR amplify TCR(3 cDNA
synthesized from mRNA expressed in these clones. The nu-
cleotide sequences are shown in Fig. 2. Among all six clones,
the TCR-(3 diversity was limited to a single VO a single DO,
and two J(3 segments. The 112-118-specific clones including
14.12, expressed V08.2/Da2.1/JO2.6, whereas clone 14.16,
which recognized 111-117 as a minimal epitope, expressed
a TCR-0 chain containing V08.2/D02.1/J62.5 (19). The
TCR (3 chains of the former groupdiffered by only two charge
conservative amino acid substitutions, both encoded by tem-
plate-independent, N-region nucleotides at the V/D and D/J
junctions. The TCR (3 chains of the SpWMb 112-118-reactive
clones and the SpWMb 111-117-reactive clones differ in both
length and sequence of their junctional regions. Alignment
of the 3' ends of their common V08.2 segment, and the
residues conserved between J02.6 and J02.5, demonstrates
that the presumptive TCR CDR3 loops of clones bearing
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Figure 2.
￿
TCR i(3 chain expression by the I-E'/110-121-specific clones was quite homogeneous. The nucleotide sequences of the TCR (3
chains expressed by the SpWMb-reactive clones were determined. The alignment is based upon common use of the VS8.2 segment.
acids. These include two tryptophane residues that contribute
bulky side chains to this region of the molecule. Notably,
8.2 and 14.12, which differ in recognition of SpWMb and
HMb, and alloreactivity, use identical TCR 0 chains, indi-
cating that these distinctions were determined by TCR a
chain residues.
Consensus MR-ciprimed PCR .
￿
In contrast to the nu-
merous mAbs directed against TCR V(3 family-specific de-
terminants (35-39), mAb reagents reactive with individual
We families are not currently available, and molecular probes
.< V--)
CACAGCCTCA GGGTACCCAG CTCTGTTCTG GTACGTGCAG TATCCCGGAG AAGGTCCACA GTTCCTCTTT AGAGCCTCAA
GGGICAAAGA GAAAGGAAGC AGCAGAGGGT TTGAAGCCAC ATACAATAAA GAAGCCACCT CCTTCCACTT GCAGAAAGCC
J-->
TCAGTGCAAG AGTCAGACTC GGCTGTGTGC TACTGCGCTT CTTTCTTTAA TAACAACAAT GCCCCAGCAT TTGGAGCGGG
C ->





GCGCCCCCGT ATTTCTTTCT TATGTTGTTT TGGATGGTTT GAAGGACAGT GGGCATTTCT
AATGGGTACA GTTACCTGCT TCTGACAGAG CTCCAGATCA AAGACTCTGC CTCATACCTC
C-O





GCACTGATGT CCATCTTCTC TGATGGTGAA AAGGAAGAAG GCAGATTTAC AGCTCAGGTC
TTCCCTACAC ATCAGAG\6C CGCMCCCAG TGACTCTGCT GTCTACCTCT GTGCAATGAG
C














exist for only 14 of the estimated 20 or more Vci families
(27-32, 40) . Northern analysis with 10 Vci family probes
did not identify Vci usage in all six SpWMb T cell clones.
To overcome the requirement for sequence information about
the target gene to define fully homologous PCR primers
flanking the region ofinterest for amplification, we designed
a degenerate 5' primer specific for a sequence that is relatively
conserved amongVca segments (see Materials and Methods).
In concert with a perfectly homologous primer specific for











GCACTGATGT CCATCTTCTC TGATGGTGAA AAGGAAGAAG GCAGATTTAC AGCTCAGGTC AATAGAGCCA GCCTGCATGT
J ~>
TTCCCTACAC ATCAGAGOAAGC CGCAAACCAG TGACTCTGCT GTCTACCTCT GTGCAATGAG CTCGGCTACT GGAGGCAATA
C -->









of the 110-121-reactive I-Ed-re-
stricted T cell clones were hetero-
geneous. Sequence analysis of the
TCR ot chains expressed in the T
cell clones was performed. Clone
8.2 is a member of the Vc14
family, clones 11.3, 12.2, 14.12,
and 14.16 are members of the Vtxl
family (27, 42). Clone 9.4 defines
a new family provisionally called
Vod5 . Given the truncation of 35
amino acids on the NHZ terminus
of the Va regions amplified in
this way, all conclusions are based
upon the identity or dissimilarity
of the COOH-terminal 2/3 of the
Vtx and entire jot segment. In-
cluded is the CDR2 segment that
differs in nucleotide sequence be-
tween different members of the
same Va family. Spaces were in-
troduced to align amino acid
residues that are highly conserved
among V regions (+). A portion
of the jct of clones 11.3, 12.2,
14.16, and 14.12 is underlined to
emphasize their partial homology.primer was used to amplify cDNA from T cell clones ex-
pressing unknownTCRVa regions (Fig . 3). To amplify many
(possibly all) Va families and include the longest possible
segment ofTCRa chain sequence with the consensus oligo
primer, we selected a segment beginning at amino acid 33,
incorporating the conservedWYXXQ motif. The resultant
PCR-amplified products are truncated at their 5' ends by
-100 bp . For applications in which full-length cDNA is
desired, a primer extension reaction, usingmRNA from the
T cells of interest as a template, can readily incorporate the
missing sequence (26) . Since the consensus primer was poten-
tially mismatched to a given Va cDNA at multiple posi-
tions, the thermal cycling conditions were modified to permit
lower stringency priming in early cycles without excessive
replication of poorly matched templates later in the reaction
(see Materials and Methods) .
TCR a Chains oftheSpWM&specic T Cell Clones.
￿
PCR
amplification of TCR-a sequences expressed by five of the
SpWMb clones was performed using the consensus Va primer
(Fig. 3) . Because of the consensus primer location, sequence
was determined for 55-60 codons ofVa, including the puta-
tive CDR2, Ja, and any bases inserted or deleted between
the V/J segments(CDR3) (Fig. 3) . Because different members
oftheknownVu families differ in nucleotide and amino acid
sequence 3' orCOON terminal of the consensus primer lo-
cation (28, 29, 32, 40), the identity of two Va segments
amplified by this method almost certainly reflects identity
of their full-length sequences . In contrast to the nearly iden-
tical TCR /3 chains expressed by the six SpWMb-reactive
clones, three Va and fourJa sequences were found among
them . Clone 8.2 expressed amember oftheVa4 family, clones
11.3, 12.2, 14.12, and 14.16 expressed a Va included in the
Val family, and clone 9.4 used a novelVa provisionally called
Va14 . One of the four Ja segments expressed in the six T
cell clones has been previously sequenced (41) . Only one clone,
14.12, expressed a jot that lacked an asp as the first amino
acid . Since there are an estimated 50 germlineJa genes (42),
many of unknown sequence, it is unclear whether this res-
idue was encoded in the germ line or arose from N-region
addition . As noted in the TCR (3 chain junctional regions,
the lengths as well as the sequences of these jot segments,
which may influence the actual conformation of the putative
Figure 4.
￿
Differences in T cell fine specificity for SpWHb are as-
sociated with both a and /3 chain junctional sequences: the presumed
CDR3 region of the TCR . SpWMb-reactive clones were tested for
epitope specificity, MHC restriction, and alloreactivity, as described in
text . The TCR from the clones were PCR amplified and sequenced
as described. A schematic representation of the receptors is shown.
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TCR-a CDR3 region, differed by up to four amino acids .
Clones 11.3, 12.2, 14.16, and 14.12 express indistinguishable
Va segments ; however, the V/Ja junctional region of 14.12
differs in sequence over a seven-amino acid stretch, and is
one residue shorter than the equivalent segment of the other
three clones. In addition, clone 14.12 differs in myoglobin
fine specificity and alloreactivity from clone 12.2 with which
it shares a common TCR a chain sequence . Therefore, both
of these differences in T cell reactivity between clones 12.2
and 14.12 map to the eight amino acids in the TCR-a junc-
tional region .
Discussion
Depicted in Fig . 4 are data for three clones, 12.2, 14.12,
and 14.16, that illustrate the major finding of this study.
Clones 12.2 and 14.16 express identical TCRa and Vfl se-
quences, demonstrating that their specificity for I-Ed plus ei-
ther SpWMb 112-118 or 111-117, respectively, arose from dis-
parities in their TCR D/Jfl region : the TCR V(3 CDR3
equivalent . Clones 12.2 and 14.12 utilized identical TCR (3
andVu sequences, but distinctTCRJot segments that con-
ferred alloantigen and antigen specificity recognition differ-
ences between these two clones (Fig. 4) . As indicated in Fig.
3, the COOH-terminal portion of thetwoJa elements that
distinguish these two clones are identical in sequence, fur-
ther refining the critical residues to those adjacent to the V/J
junction (the presumed CDR3a) . Thus, differences in ei-
ther the presumptiveCDR3a or theCDR30 sequence gener-
ated functional alterations in T cell recognition of antigenic
peptides despite identical MHC restriction of these clones .
Several additional points arise from theTCR sequence data
reported here. Clones of indistinguishable MHC/antigen
specificity (8.2, 9.4, 11.3, 12.2) expressed a virtually invar-
iantTCR0 chain and threeValja combinations, suggesting
that similar receptor-binding sites can be generated by mul-
tipleTCR a chains paired with a givenTCR (3 chain. How-
ever, evaluation of the reactivity of these four clones to pep-
tides containing substitutions in the 110-121 residues (studies
now in progress) is necessary to conclude that epitope recog-
nition, conferred by all threeTCRa sequences, is identical .
Previous analysis of T cell clones specific for the NH2 ter-
minus of myelin basic protein has also demonstrated that
multiple combinations ofTCR V/Ja paired with a V08 .2-
containing TCR a chain can afford nearly identical anti-
gen-binding sites (15, 43) .
Prior studies of cytochrome C-reactive T cells suggested
that a single, highly conserved TCR a chain amino acid at
the V/D junction was important in peptide specificity (12,
44) . Site-specific mutation of this residue resulted in decreased
alloreactivity and cytochrome C dose response, without con-
comitant effects onMHC restriction (45) . Since most ofthe
COOH-terminal portion of the Jai segments expressed by
clones 12.2 and 14.16 are homologous, the fine specificity
difference maps to the DO1 JO junction and the first few
residues of the J/3 germline elements . Within this confined
region, the TCR a chains of the clones vary in length by
four amino acids . The Fab model of the TCR predicts thatthese residues comprise the CDR3ß loop; thus, its confor-
mation should differ substantially between clones 11.3 and
14.16. Mutagenesis experiments will be required to deter-
mine how the length and amino acid composition of the puta-
tive CDR3ß affects peptide recognition.
Generation of a portion of these data has been dependent
upon a modification of the PCR technique that permitted
amplification of TCR a chains without prior assignment of
theVa segments they contain, through use of a degenerate,
consensus 5' oligonucleotide primer. Application of this con-
sensus primer PCR modification can be extended to ques-
tions of TCR a chain repertoire of rare cells within clonally
diverse populations in vivo, as well as T cell clones. Analysis
of amplified a chains from unfractionated thymocytes indi-
cated that allVa families for which we currently have probes
(Vor 1-8, 10, 11, 13) were readily detectable in the PCR prod-
ucts, confirmingthebroad specificity of the degenerate primers.
Recent experiments have indicated that this consensus PCR
technique is sufficiently sensitive to allow TCR-a sequence
assessment from aliquots of 10 thymocytes (Guidos, CJ., J.S.
Danska, C.G. Fathman, and I.L. Weissman, manuscript sub-
mitted for publication) .
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